TreeWAS – Variant ID: rs652722

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K86.8 Other specified diseases of pancreas	0.000	0.979	0.021
K86 Other diseases of pancreas	0.000	0.980	0.020
K86.3 Pseudocyst of pancreas	0.000	0.981	0.019
K86.1 Other chronic pancreatitis	0.000	0.982	0.018
K86.0 Alcohol-induced chronic pancreatitis	0.000	0.982	0.018
N83.9 Noninflammatory disorder of ovary, Fallopian tube and broad ligament, unspecified	0.016	0.984	0.000
N83.1 Corpus luteum cyst	0.016	0.984	0.000
N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.014	0.986	0.000
K86.2 Cyst of pancreas	0.000	0.987	0.013
N89.8 Other specified noninflammatory disorders of vagina	0.013	0.987	0.000
N83.0 Follicular cyst of ovary	0.012	0.988	0.000
C91.1 Chronic lymphocytic leukaemia	0.000	0.988	0.012
K86.9 Disease of pancreas, unspecified	0.000	0.988	0.012
N83.4 Prolapse and hernia of ovary and Fallopian tube	0.011	0.989	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.010	0.990	0.000
N83.6 Haematosalpinx	0.010	0.990	0.000
Y45.2 Propionic acid derivatives	0.010	0.990	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.010	0.990	0.000
N83.7 Haematoma of broad ligament	0.010	0.990	0.000
N83.2 Other and unspecified ovarian cysts	0.010	0.990	0.000
Y45.1 Salicylates	0.010	0.990	0.000
Y45.0 Opioids and related analgesics	0.009	0.991	0.000
N83.5 Torsion of ovary, ovarian pedicle and Fallopian tube	0.008	0.992	0.000
D61.9 Aplastic anaemia, unspecified	0.000	0.992	0.008
Y45.4 Antirheumatics	0.007	0.992	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.008	0.992	0.000
Y45.5 4-Aminophenol derivatives	0.007	0.993	0.000
C91 Lymphoid leukaemia	0.000	0.993	0.007
Y52 Agents primarily affecting the cardiovascular system	0.007	0.993	0.000
N83.3 Acquired atrophy of ovary and Fallopian tube	0.007	0.993	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.006	0.994	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.006	0.994	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.006	0.994	0.000
Y52.1 Calcium-channel blockers	0.006	0.994	0.000
C91.9 Lymphoid leukaemia, unspecified	0.000	0.994	0.006
C91.4 Hairy-cell leukaemia	0.000	0.994	0.006
O64.0 Obstructed labour due to incomplete rotation of foetal head	0.006	0.994	0.000
C77.1 Intrathoracic lymph nodes	0.000	0.994	0.006
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.006	0.994	0.000
Y52.7 Peripheral vasodilators	0.006	0.994	0.000
S82.60 Fracture of lateral malleolus (closed)	0.006	0.994	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.000	0.994	0.005
C91.7 Other lymphoid leukaemia	0.000	0.994	0.005
C91.6 Prolymphocytic leukaemia of T-cell type	0.000	0.994	0.005
C91.3 Prolymphocytic leukaemia	0.000	0.994	0.005
C91.2 Subacute lymphocytic leukaemia	0.000	0.994	0.005
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.005	0.994	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.005	0.995	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.005	0.995	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.005	0.995	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.005	0.995	0.000
Y45.8 Other analgesics and antipyretics	0.005	0.995	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.005	0.995	0.000
C91.5 Adult T-cell leukaemia	0.000	0.995	0.005
F45.8 Other somatoform disorders	0.000	0.995	0.005
C81.1 Nodular sclerosis	0.000	0.995	0.005
Y59 Other and unspecified vaccines and biological substances	0.005	0.995	0.000
S09.9 Unspecified injury of head	0.005	0.995	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.005	0.995	0.000
Y46.6 Other and unspecified antiepileptics	0.005	0.995	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.005	0.995	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.005	0.995	0.000
Y57.8 Other drugs and medicaments	0.004	0.996	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.004	0.996	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.004	0.996	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.004	0.996	0.000
Y44 Agents primarily affecting blood constituents	0.004	0.996	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
T84.0 Mechanical complication of internal joint prosthesis	0.004	0.996	0.000
Y46.2 Hydantoin derivatives	0.004	0.996	0.000
Y56.3 Emollients, demulcents and protectants	0.004	0.996	0.000
Y58 Bacterial vaccines	0.004	0.996	0.000
Y59.0 Viral vaccines	0.004	0.996	0.000
Y56.9 Topical agent, unspecified	0.004	0.996	0.000
Y56.8 Other topical agents	0.004	0.996	0.000
Y56.7 Dental drugs, topically applied	0.004	0.996	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.004	0.996	0.000
Y56.5 Ophthalmological drugs and preparations	0.004	0.996	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.004	0.996	0.000
Y56.2 Local astringents and local detergents	0.004	0.996	0.000
Y56.1 Antipruritics	0.004	0.996	0.000
T83.4 Mechanical complication of other prosthetic devices, implants and grafts in genital tract	0.004	0.996	0.000
S12.90 Fracture of neck, part unspecified (closed)	0.004	0.996	0.000
C81 Hodgkin's disease	0.000	0.996	0.004
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
Y57 Other and unspecified drugs and medicaments	0.004	0.996	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.996	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.000	0.996	0.004
Y46.8 Antispasticity drugs	0.004	0.996	0.000
Y46.5 Valproic acid	0.004	0.996	0.000
Y46.3 Deoxybarbiturates	0.004	0.996	0.000
Y46.1 Oxazolidinediones	0.004	0.996	0.000
Y46.0 Succinimides	0.004	0.996	0.000
Y59.3 Immunoglobulin	0.004	0.996	0.000
Y46.7 Anti-Parkinsonism drugs	0.004	0.996	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.004	0.996	0.000
Y46.4 Iminostilbenes	0.004	0.996	0.000
Y59.9 Vaccine or biological substance, unspecified	0.004	0.996	0.000
Y59.8 Other specified vaccines and biological substances	0.004	0.996	0.000
Y59.2 Protozoal vaccines	0.004	0.996	0.000
Y59.1 Rickettsial vaccines	0.004	0.996	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.004	0.996	0.000
D61 Other aplastic anaemias	0.000	0.996	0.004
I84.0 Internal thrombosed haemorrhoids	0.000	0.996	0.004
Y41.1 Antimycobacterial drugs	0.004	0.996	0.000
Y48 Anaesthetics and therapeutic gases	0.004	0.996	0.000
C91.0 Acute lymphoblastic leukaemia	0.000	0.996	0.003
Y54.7 Agents affecting calcification	0.004	0.996	0.000
T84.1 Mechanical complication of internal fixation device of bones of limb	0.004	0.996	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.000	0.996	0.004
Y54.3 Benzothiadiazine derivatives	0.004	0.996	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.996	0.000
Y53.7 Emetics	0.003	0.996	0.000
Y53.6 Antidiarrhoeal drugs	0.003	0.996	0.000
Y53.5 Digestants	0.003	0.996	0.000
Y53.3 Saline and osmotic laxatives	0.003	0.996	0.000
Y53.2 Stimulant laxatives	0.003	0.996	0.000
Y53.0 Histamine H2-receptor antagonists	0.003	0.996	0.000
C90.2 Plasmacytoma, extramedullary	0.000	0.996	0.004
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.996	0.000
Y41.4 Anthelminthics	0.003	0.996	0.000
Y41.3 Other antiprotozoal drugs	0.003	0.996	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.996	0.000
Y41.0 Sulphonamides	0.003	0.996	0.000
Y44.5 Thrombolytic drugs	0.003	0.996	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.003	0.996	0.000
S82.6 Fracture of lateral malleolus	0.003	0.996	0.000
Y53.4 Other laxatives	0.003	0.996	0.000
Y47.1 Benzodiazepines	0.003	0.996	0.000
Y54.8 Agents affecting uric acid metabolism	0.003	0.997	0.000
C92.1 Chronic myeloid leukaemia	0.000	0.997	0.003
I27.0 Primary pulmonary hypertension	0.003	0.997	0.000
R25.2 Cramp and spasm	0.000	0.997	0.003
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.003	0.997	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.003	0.997	0.000
Y47.4 Bromine compounds	0.003	0.997	0.000
Y47.3 Paraldehyde	0.003	0.997	0.000
Y47.2 Chloral derivatives	0.003	0.997	0.000
Y47.0 Barbiturates, not elsewhere classified	0.003	0.997	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.000	0.997	0.003
N70.1 Chronic salpingitis and oophoritis	0.000	0.997	0.003
Y50.9 Central nervous system stimulant, unspecified	0.003	0.997	0.000
Y50.8 Other central nervous system stimulants	0.003	0.997	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.003	0.997	0.000
Y50.1 Opioid receptor antagonists	0.003	0.997	0.000
Y50.0 Analeptics	0.003	0.997	0.000
Y54.9 Mineral salts, not elsewhere classified	0.003	0.997	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.003	0.997	0.000
Y54.0 Mineralocorticoids	0.003	0.997	0.000
Y44.2 Anticoagulants	0.003	0.997	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.003	0.997	0.000
Y44.7 Plasma substitutes	0.003	0.997	0.000
Y44.6 Natural blood and blood products	0.003	0.997	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.003	0.997	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.003	0.997	0.000
C92 Myeloid leukaemia	0.000	0.997	0.003
H66.3 Other chronic suppurative otitis media	0.003	0.997	0.000
Y48.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
Y55.5 Anticommon cold drugs	0.003	0.997	0.000
Y55.4 Expectorants	0.003	0.997	0.000
Y55.3 Antitussives	0.003	0.997	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
Y55.0 Oxytocic drugs	0.003	0.997	0.000
J81 Pulmonary oedema	0.003	0.997	0.000
Y58.9 Other and unspecified bacterial vaccines	0.003	0.997	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.003	0.997	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.003	0.997	0.000
Y58.5 Diphtheria vaccine	0.003	0.997	0.000
Y58.4 Tetanus vaccine	0.003	0.997	0.000
Y58.3 Plague vaccine	0.003	0.997	0.000
Y58.2 Cholera vaccine	0.003	0.997	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.003	0.997	0.000
C88 Malignant immunoproliferative diseases	0.000	0.997	0.003
Y41.5 Antiviral drugs	0.003	0.997	0.000
S40.0 Contusion of shoulder and upper arm	0.003	0.997	0.000
C95 Leukaemia of unspecified cell type	0.000	0.997	0.003
Y55.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.000	0.997	0.003
C81.3 Lymphocytic depletion	0.000	0.997	0.003
Y57.7 Vitamins, not elsewhere classified	0.003	0.997	0.000
Y57.4 Pharmaceutical excipients	0.003	0.997	0.000
Y57.3 Alcohol deterrents	0.003	0.997	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
Y57.1 Lipotropic drugs	0.003	0.997	0.000
Y57.0 Appetite depressants [anorectics]	0.003	0.997	0.000
C81.7 Other Hodgkin's disease	0.000	0.997	0.003
Y58.0 BCG vaccine	0.003	0.997	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.997	0.003
C94 Other leukaemias of specified cell type	0.000	0.997	0.003
C81.0 Lymphocytic predominance	0.000	0.997	0.003
S62.50 Fracture of thumb (closed)	0.003	0.997	0.000
C81.9 Hodgkin's disease, unspecified	0.000	0.997	0.003
S12.9 Fracture of neck, part unspecified	0.003	0.997	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.003	0.997	0.000
C83.1 Small cleaved cell (diffuse)	0.000	0.997	0.003
D61.1 Drug-induced aplastic anaemia	0.000	0.997	0.003
M84.12 Nonunion of fracture [pseudarthrosis] (Upper arm)	0.003	0.997	0.000
N88.9 Noninflammatory disorder of cervix uteri, unspecified	0.003	0.997	0.000
D61.8 Other specified aplastic anaemias	0.000	0.997	0.003
D61.3 Idiopathic aplastic anaemia	0.000	0.997	0.003
D61.2 Aplastic anaemia due to other external agents	0.000	0.997	0.003
D61.0 Constitutional aplastic anaemia	0.000	0.997	0.003
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.000	0.997	0.003
C90.3 Solitary plasmacytoma	0.000	0.997	0.003
C90.0 Multiple myeloma	0.000	0.997	0.003
Y48.5 Therapeutic gases	0.003	0.997	0.000
Y48.1 Parenteral anaesthetics	0.003	0.997	0.000
Y48.0 Inhaled anaesthetics	0.003	0.997	0.000
N88.2 Stricture and stenosis of cervix uteri	0.003	0.997	0.000
C93 Monocytic leukaemia	0.000	0.997	0.003
R25.1 Tremor, unspecified	0.000	0.997	0.003
S80.9 Superficial injury of lower leg, unspecified	0.003	0.997	0.000
R25.8 Other and unspecified abnormal involuntary movements	0.000	0.997	0.003
Y49.5 Other antipsychotics and neuroleptics	0.003	0.997	0.000
C83.0 Small cell (diffuse)	0.000	0.997	0.003
M84.1 Nonunion of fracture [pseudarthrosis]	0.003	0.997	0.000
C86 Other specified types of T/NK-cell lymphoma	0.000	0.997	0.003
R25 Abnormal involuntary movements	0.000	0.997	0.003
C88.0 Waldenstrom's macroglobulinaemia	0.000	0.997	0.003
K13.7 Other and unspecified lesions of oral mucosa	0.003	0.997	0.000
Y49.9 Psychotropic drug, unspecified	0.003	0.997	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
Y49.7 Psychostimulants with abuse potential	0.003	0.997	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.003	0.997	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
S82.61 Fracture of lateral malleolus (open)	0.003	0.997	0.000
C81.2 Mixed cellularity	0.000	0.997	0.003
F45 Somatoform disorders	0.000	0.997	0.003
Y57.6 Other diagnostic agents	0.003	0.997	0.000
C92.9 Myeloid leukaemia, unspecified	0.000	0.997	0.003
G82.5 Tetraplegia, unspecified	0.003	0.997	0.000
N71.9 Inflammatory disease of uterus, unspecified	0.003	0.997	0.000
C83.6 Undifferentiated (diffuse)	0.000	0.997	0.003
C83.5 Lymphoblastic (diffuse)	0.000	0.997	0.003
C83.4 Immunoblastic (diffuse)	0.000	0.997	0.003
C83.2 Mixed small and large cell (diffuse)	0.000	0.997	0.003
C95.9 Leukaemia, unspecified	0.000	0.997	0.003
C92.4 Acute promyelocytic leukaemia	0.000	0.997	0.003
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.000	0.997	0.003
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.000	0.997	0.003
C92.5 Acute myelomonocytic leukaemia	0.000	0.997	0.003
C92.3 Myeloid sarcoma	0.000	0.997	0.003
C92.2 Subacute myeloid leukaemia	0.000	0.997	0.003
M96.1 Postlaminectomy syndrome, not elsewhere classified	0.003	0.997	0.000
R87.7 Abnormal histological findings	0.003	0.997	0.000
Y54.5 Other diuretics	0.002	0.997	0.000
Y54.4 Loop [high-ceiling] diuretics	0.002	0.997	0.000
T84 Complications of internal orthopaedic prosthetic devices, implants and grafts	0.003	0.997	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.000	0.997	0.002
C88.7 Other malignant immunoproliferative diseases	0.000	0.997	0.002
C88.3 Immunoproliferative small intestinal disease	0.000	0.997	0.002
C88.2 Gamma heavy chain disease	0.000	0.997	0.002
C88.1 Alpha heavy chain disease	0.000	0.997	0.002
C92.7 Other myeloid leukaemia	0.000	0.997	0.003
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.000	0.997	0.003
R85.7 Abnormal histological findings	0.003	0.997	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.000	0.997	0.003
M84.16 Nonunion of fracture [pseudarthrosis] (Lower leg)	0.003	0.997	0.000
T84.3 Mechanical complication of other bone devices, implants and grafts	0.003	0.997	0.000
C95.7 Other leukaemia of unspecified cell type	0.000	0.997	0.002
C95.2 Subacute leukaemia of unspecified cell type	0.000	0.997	0.002
C95.0 Acute leukaemia of unspecified cell type	0.000	0.997	0.002
M84.11 Nonunion of fracture [pseudarthrosis] (Shoulder region)	0.003	0.997	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.000	0.997	0.002
E14.9 Without complications	0.000	0.997	0.003
Y48.4 Anaesthetic, unspecified	0.002	0.997	0.000
F45.3 Somatoform autonomic dysfunction	0.000	0.997	0.003
R85 Abnormal findings in specimens from digestive organs and abdominal cavity	0.003	0.997	0.000
S82.20 Fracture of shaft of tibia (closed)	0.003	0.997	0.000
C90.1 Plasma cell leukaemia	0.000	0.997	0.002
C94.7 Other specified leukaemias	0.000	0.997	0.002
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.000	0.997	0.002
C94.5 Acute myelofibrosis	0.000	0.997	0.002
C94.4 Acute panmyelosis	0.000	0.997	0.002
C94.3 Mast cell leukaemia	0.000	0.997	0.002
C94.2 Acute megakaryoblastic leukaemia	0.000	0.997	0.002
C94.1 Chronic erythraemia	0.000	0.997	0.002
C94.0 Acute erythraemia and erythroleukaemia	0.000	0.997	0.002
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.000	0.997	0.002
C96.8 Histiocytic sarcoma	0.000	0.997	0.002
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.997	0.002
C96.6 Unifocal Langerhans-cell histiocytosis	0.000	0.997	0.002
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.000	0.997	0.002
C96.4 Sarcoma of dendritic cells (accessory cells)	0.000	0.997	0.002
C96.3 True histiocytic lymphoma	0.000	0.997	0.002
C96.2 Malignant mast cell tumour	0.000	0.997	0.002
C96.1 Malignant histiocytosis	0.000	0.997	0.002
C96.0 Letterer-Siwe disease	0.000	0.997	0.002
O42.1 Premature rupture of membranes, onset of labour after 24 hours	0.000	0.997	0.003
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.997	0.000
M84.17 Nonunion of fracture [pseudarthrosis] (Ankle and foot)	0.003	0.997	0.000
C83.7 Burkitt's tumour	0.000	0.997	0.002
C95.1 Chronic leukaemia of unspecified cell type	0.000	0.997	0.002
R85.8 Other abnormal findings	0.002	0.997	0.000
Y57.5 X-ray contrast media	0.002	0.997	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.002	0.997	0.000
I27.2 Other secondary pulmonary hypertension	0.003	0.997	0.000
N88 Other noninflammatory disorders of cervix uteri	0.003	0.997	0.000
C83.3 Large cell (diffuse)	0.000	0.997	0.002
I27 Other pulmonary heart diseases	0.002	0.997	0.000
S12.91 Fracture of neck, part unspecified (open)	0.002	0.998	0.000
T84.2 Mechanical complication of internal fixation device of other bones	0.002	0.998	0.000
S82.81 Fractures of other parts of lower leg (open)	0.002	0.998	0.000
F45.0 Somatisation disorder	0.000	0.998	0.002
T84.7 Infection and inflammatory reaction due to other internal orthopaedic prosthetic devices, implants and grafts	0.002	0.998	0.000
S62.51 Fracture of thumb (open)	0.002	0.998	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.000	0.998	0.002
M84.15 Nonunion of fracture [pseudarthrosis] (Pelvic region and thigh)	0.002	0.998	0.000
C25.0 Head of pancreas	0.002	0.998	0.000
C93.9 Monocytic leukaemia, unspecified	0.000	0.998	0.002
C93.7 Other monocytic leukaemia	0.000	0.998	0.002
C93.3 Juvenile myelomonocytic leukaemia	0.000	0.998	0.002
C93.2 Subacute monocytic leukaemia	0.000	0.998	0.002
C93.0 Acute monocytic leukaemia	0.000	0.998	0.002
S82.8 Fractures of other parts of lower leg	0.002	0.998	0.000
E13.9 Without complications	0.000	0.998	0.002
H66 Suppurative and unspecified otitis media	0.002	0.998	0.000
H74.1 Adhesive middle ear disease	0.002	0.998	0.000
J30.1 Allergic rhinitis due to pollen	0.002	0.998	0.000
M84.19 Nonunion of fracture [pseudarthrosis] (Site unspecified)	0.002	0.998	0.000
M84.10 Nonunion of fracture [pseudarthrosis] (Multiple sites)	0.002	0.998	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.000	0.998	0.002
C86.4 Blastic NK-cell lymphoma	0.000	0.998	0.002
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.000	0.998	0.002
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.000	0.998	0.002
C86.1 Hepatosplenic T-cell lymphoma	0.000	0.998	0.002
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.000	0.998	0.002
I27.9 Pulmonary heart disease, unspecified	0.002	0.998	0.000
R25.0 Abnormal head movements	0.000	0.998	0.002
R89.5 Abnormal microbiological findings	0.002	0.998	0.000
S64.4 Injury of digital nerve of other finger	0.002	0.998	0.000
R89 Abnormal findings in specimens from other organs, systems and tissues	0.002	0.998	0.000
H66.9 Otitis media, unspecified	0.002	0.998	0.000
S82.80 Fractures of other parts of lower leg (closed)	0.002	0.998	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.000	0.998	0.002
F45.4 Persistent somatoform pain disorder	0.000	0.998	0.002
F45.1 Undifferentiated somatoform disorder	0.000	0.998	0.002
F45.2 Hypochondriacal disorder	0.000	0.998	0.002
F81.9 Developmental disorder of scholastic skills, unspecified	0.000	0.998	0.002
R83-R89 Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis	0.002	0.998	0.000
O64.9 Obstructed labour due to malposition and malpresentation, unspecified	0.002	0.998	0.000
T51.9 Alcohol, unspecified	0.002	0.998	0.000
R86 Abnormal findings in specimens from male genital organs	0.002	0.998	0.000
C84.0 Mycosis fungoides	0.000	0.998	0.002
N88.1 Old laceration of cervix uteri	0.002	0.998	0.000
O64 Obstructed labour due to malposition and malpresentation of foetus	0.002	0.998	0.000
Y40 Systemic antibiotics	0.002	0.998	0.000
M84.41 Pathological fracture, not elsewhere classified (Shoulder region)	0.002	0.998	0.000
S12 Fracture of neck	0.002	0.998	0.000
M84.18 Nonunion of fracture [pseudarthrosis] (Other)	0.002	0.998	0.000
M84.13 Nonunion of fracture [pseudarthrosis] (Forearm)	0.002	0.998	0.000
O30.0 Twin pregnancy	0.000	0.998	0.002
S62.5 Fracture of thumb	0.002	0.998	0.000
S82.2 Fracture of shaft of tibia	0.002	0.998	0.000
T84.8 Other complications of internal orthopaedic prosthetic devices, implants and grafts	0.002	0.998	0.000
X59.4 Street and highway	0.002	0.998	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.000	0.998	0.002
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.000	0.998	0.002
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.000	0.998	0.002
C84.3 Lymphoepithelioid lymphoma	0.000	0.998	0.002
C84.2 T-zone lymphoma	0.000	0.998	0.002
C84.1 Sezary's diease	0.000	0.998	0.002
K65.9 Peritonitis, unspecified	0.002	0.998	0.000
G82 Paraplegia and tetraplegia	0.002	0.998	0.000
C93.1 Chronic monocytic leukaemia	0.000	0.998	0.002
Y48.3 Local anaesthetics	0.002	0.998	0.000
Y49.2 Other and unspecified antidepressants	0.002	0.998	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.000	0.998	0.002
E85.9 Amyloidosis, unspecified	0.000	0.998	0.002
R86.8 Other abnormal findings	0.002	0.998	0.000
R87 Abnormal findings in specimens from female genital organs	0.002	0.998	0.000
H66.2 Chronic atticoantral suppurative otitis media	0.002	0.998	0.000
N83.8 Other noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.002	0.998	0.000
R47.0 Dysphasia and aphasia	0.000	0.998	0.002
R85.9 Unspecified abnormal finding	0.002	0.998	0.000
R85.6 Abnormal cytological findings	0.002	0.998	0.000
R85.4 Abnormal immunological findings	0.002	0.998	0.000
R85.3 Abnormal level of substances chiefly nonmedicinal as to source	0.002	0.998	0.000
R85.2 Abnormal level of other drugs, medicaments and biological substances	0.002	0.998	0.000
R85.1 Abnormal level of hormones	0.002	0.998	0.000
R85.0 Abnormal level of enzymes	0.002	0.998	0.000
X59 Exposure to unspecified factor	0.002	0.998	0.000
C84.5 Other and unspecified T-cell lymphomas	0.000	0.998	0.002
G82.1 Spastic paraplegia	0.002	0.998	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.000	0.998	0.002
N13.2 Hydronephrosis with renal and ureteral calculous obstruction	0.002	0.998	0.000
T84.9 Unspecified complication of internal orthopaedic prosthetic device, implant and graft	0.002	0.998	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
Y51.0 Anticholinesterase agents	0.002	0.998	0.000
N88.4 Hypertrophic elongation of cervix uteri	0.002	0.998	0.000
N88.3 Incompetence of cervix uteri	0.002	0.998	0.000
N88.0 Leukoplakia of cervix uteri	0.002	0.998	0.000
R89.7 Abnormal histological findings	0.002	0.998	0.000
Y57.9 Drug or medicament, unspecified	0.002	0.998	0.000
I27.1 Kyphoscoliotic heart disease	0.002	0.998	0.000
S12.1 Fracture of second cervical vertebra	0.002	0.998	0.000
M84.4 Pathological fracture, not elsewhere classified	0.002	0.998	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.002	0.998	0.000
M84.14 Nonunion of fracture [pseudarthrosis] (Hand)	0.002	0.998	0.000
F10.0 Acute intoxication	0.002	0.998	0.000
F45.9 Somatoform disorder, unspecified	0.000	0.998	0.002
Y42.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
X59.2 School, other institution and public administrative area	0.002	0.998	0.000
S82 Fracture of lower leg, including ankle	0.002	0.998	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.000	0.998	0.002
C85.0 Lymphosarcoma	0.000	0.998	0.002
C86.5 Angioimmunoblastic T-cell lymphoma	0.000	0.998	0.002
H65.9 Nonsuppurative otitis media, unspecified	0.002	0.998	0.000
M96.8 Other postprocedural musculoskeletal disorders	0.002	0.998	0.000
S82.86 Maisonneuve's fracture	0.002	0.998	0.000
G82.2 Paraplegia, unspecified	0.002	0.998	0.000
H66.4 Suppurative otitis media, unspecified	0.002	0.998	0.000
K25.3 Acute without haemorrhage or perforation	0.000	0.998	0.002
N88.8 Other specified noninflammatory disorders of cervix uteri	0.002	0.998	0.000
R85.5 Abnormal microbiological findings	0.002	0.998	0.000
M84 Disorders of continuity of bone	0.002	0.998	0.000
S12.10 Fracture of second cervical vertebra (closed)	0.002	0.998	0.000
R86.7 Abnormal histological findings	0.002	0.998	0.000
X59.3 Sports and athletics area	0.002	0.998	0.000
R89.9 Unspecified abnormal finding	0.002	0.998	0.000
R89.8 Other abnormal findings	0.002	0.998	0.000
R89.6 Abnormal cytological findings	0.002	0.998	0.000
R89.4 Abnormal immunological findings	0.002	0.998	0.000
R89.3 Abnormal level of substances chiefly nonmedicinal as to source	0.002	0.998	0.000
R89.2 Abnormal level of other drugs, medicaments and biological substances	0.002	0.998	0.000
R89.1 Abnormal level of hormones	0.002	0.998	0.000
R89.0 Abnormal level of enzymes	0.002	0.998	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
C82.0 Small cleaved cell, follicular	0.000	0.998	0.002
R86.6 Abnormal cytological findings	0.002	0.998	0.000
W06.0 Home	0.000	0.998	0.002
M84.45 Pathological fracture, not elsewhere classified (Pelvic region and thigh)	0.002	0.998	0.000
R25.3 Fasciculation	0.000	0.998	0.002
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
C82.2 Large cell, follicular	0.000	0.998	0.002
H66.0 Acute suppurative otitis media	0.002	0.998	0.000
R86.9 Unspecified abnormal finding	0.002	0.998	0.000
R86.5 Abnormal microbiological findings	0.002	0.998	0.000
R86.4 Abnormal immunological findings	0.002	0.998	0.000
R86.3 Abnormal level of substances chiefly nonmedicinal as to source	0.002	0.998	0.000
R86.2 Abnormal level of other drugs, medicaments and biological substances	0.002	0.998	0.000
R86.1 Abnormal level of hormones	0.002	0.998	0.000
R86.0 Abnormal level of enzymes	0.002	0.998	0.000
Y42.2 Antithyroid drugs	0.002	0.998	0.000
R83 Abnormal findings in cerebrospinal fluid	0.002	0.998	0.000
O64.5 Obstructed labour due to compound presentation	0.002	0.998	0.000
O64.4 Obstructed labour due to shoulder presentation	0.002	0.998	0.000
O64.3 Obstructed labour due to brow presentation	0.002	0.998	0.000
O64.2 Obstructed labour due to face presentation	0.002	0.998	0.000
Y40.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
Y40.6 Rifamycins	0.002	0.998	0.000
Y40.4 Tetracyclines	0.002	0.998	0.000
Y40.2 Chloramphenicol group	0.002	0.998	0.000
O64.8 Obstructed labour due to other malposition and malpresentation	0.002	0.998	0.000
R87.9 Unspecified abnormal finding	0.002	0.998	0.000
S12.8 Fracture of other parts of neck	0.002	0.998	0.000
S12.0 Fracture of first cervical vertebra	0.002	0.998	0.000
S12.7 Multiple fractures of cervical spine	0.002	0.998	0.000
S80 Superficial injury of lower leg	0.002	0.998	0.000
G82.3 Flaccid tetraplegia	0.002	0.998	0.000
G82.0 Flaccid paraplegia	0.002	0.998	0.000
M84.2 Delayed union of fracture	0.002	0.998	0.000
R87.8 Other abnormal findings	0.002	0.998	0.000
R87.5 Abnormal microbiological findings	0.002	0.998	0.000
R87.4 Abnormal immunological findings	0.002	0.998	0.000
R87.3 Abnormal level of substances chiefly nonmedicinal as to source	0.002	0.998	0.000
R87.2 Abnormal level of other drugs, medicaments and biological substances	0.002	0.998	0.000
R87.1 Abnormal level of hormones	0.002	0.998	0.000
R87.0 Abnormal level of enzymes	0.002	0.998	0.000
N71 Inflammatory disease of uterus, except cervix	0.002	0.998	0.000
R84 Abnormal findings in specimens from respiratory organs and thorax	0.002	0.998	0.000
S80.0 Contusion of knee	0.002	0.998	0.000
S82.9 Fracture of lower leg, part unspecified	0.002	0.998	0.000
X59.9 Unspecified place	0.002	0.998	0.000
X59.8 Other specified place	0.002	0.998	0.000
X59.0 Home	0.002	0.998	0.000
X59.7 Farm	0.002	0.998	0.000
X59.6 Industrial and construction area	0.002	0.998	0.000
X59.5 Trade and service area	0.002	0.998	0.000
X59.1 Residential institution	0.002	0.998	0.000
M84.42 Pathological fracture, not elsewhere classified (Upper arm)	0.002	0.998	0.000
C82.6 Cutaneous follicle centre lymphoma	0.000	0.998	0.002
C82.5 Diffuse follicle centre lymphoma	0.000	0.998	0.002
C82.4 Follicular lymphoma grade IIIb	0.000	0.998	0.002
N71.0 Acute inflammatory disease of uterus	0.002	0.998	0.000
S12.2 Fracture of other specified cervical vertebra	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations